Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urogenital Neoplasms × Abiraterone Acetate × Clear all

Sponsor

Conditions

Prostatic Neoplasms 62 Neoplasm Metastasis 6 Prostatic Neoplasms, Castration-Resistant 4 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Prostate Cancer Metastatic 2 Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Metastatic Castration-sensitive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Hyperaldosteronism 1 Castration-resistant Prostate Cancer 1 Adenocarcinoma 1

Interventions

Sunitinib 2 Paclitaxel 2 valrubicin 1 temsirolimus 1 sipuleucel-T 1 luprolide acetate gel depot 1 ferumoxtran-10 1 abiraterone 1 abemaciclib 1 Suspensions 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Powders 1 Pemetrexed 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Educational Status 1 Docetaxel 1 Bevacizumab 1 Administration, Intravesical 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡